We are sharing a specialised consulting opportunity for experienced Pharmacovigilance and Drug Safety professionals with strong expertise in DSURs, PSURs/PBRERs, aggregate safety analysis, signal management, benefit-risk assessment, MedDRA coding, and regulatory safety documentation to contribute to an advanced AI training and pharmacovigilance evaluation project. Work will involve DSUR and PSUR/PBRER review, aggregate safety analysis, signal management, benefit-risk assessment, MedDRA coding, case-level review, data reconciliation, and regulatory documentation.